Lipocine Historical Cash Flow
| LPCN Stock | USD 5.44 0.12 2.26% |
Analysis of Lipocine cash flow over time is an excellent tool to project Lipocine future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 1 M or Capital Expenditures of 12.5 K as it is a great indicator of Lipocine ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Lipocine latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lipocine is a good buy for the upcoming year.
Lipocine |
About Lipocine Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Lipocine balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Lipocine's non-liquid assets can be easily converted into cash.
Lipocine Cash Flow Chart
Lipocine Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Lipocine Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Lipocine's Depreciation is very stable compared to the past year. As of the 19th of April 2024, Other Cashflows From Investing Activities is likely to grow to about 3.6 M, while Free Cash Flow is likely to drop (12.5 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Lipocine's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Lipocine current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.At this time, Lipocine's Depreciation is very stable compared to the past year. As of the 19th of April 2024, Other Cashflows From Investing Activities is likely to grow to about 3.6 M, while Free Cash Flow is likely to drop (12.5 M).
Lipocine cash flow statement Correlations
Click cells to compare fundamentals
Lipocine Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lipocine cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.7M | 9.5M | (21.3M) | 197.9K | 1.6M | 1.7M | |
| Free Cash Flow | (11.7M) | (15.3M) | (4.4M) | (12.1M) | (11.9M) | (12.5M) | |
| Change In Working Capital | 469.3K | 1.5M | (4.6M) | (923.6K) | 2.0M | 2.1M | |
| Other Cashflows From Financing Activities | 56.4K | 7.9M | 11.7K | 14.3M | 13.1M | 13.7M | |
| Other Non Cash Items | 221.2K | 109.3K | 53.8K | (932.1K) | 973.5K | 1.0M | |
| Total Cash From Operating Activities | (11.7M) | (15.3M) | (4.4M) | (12.0M) | (11.9M) | (12.5M) | |
| Net Income | (13.0M) | (21.0M) | (634.4K) | (10.8M) | (16.4M) | (17.2M) | |
| Total Cash From Financing Activities | 10.3M | 20.9M | 26.9M | (2.1M) | 404.6K | 384.3K | |
| End Period Cash Flow | 14.7M | 24.2M | 3.0M | 3.1M | 4.8M | 4.5M | |
| Change To Netincome | 799.4K | 4.0M | 248.1K | (296.0K) | (340.4K) | (323.4K) | |
| Sale Purchase Of Stock | 13.7M | 13.3M | 26.9M | (21.7K) | (25.0K) | (23.7K) | |
| Begin Period Cash Flow | 13.1M | 14.7M | 24.2M | 3.0M | 3.1M | 3.0M | |
| Total Cashflows From Investing Activities | 3.0M | 3.9M | (43.8M) | 14.3M | 12.9M | 13.5M | |
| Depreciation | 15.4K | 3.6K | 380.0 | 9.5K | 28.7K | 30.1K | |
| Cash And Cash Equivalents Changes | 9.9M | 1.7M | 9.5M | (21.3M) | (19.1M) | (18.2M) | |
| Change To Liabilities | 473.1K | 1.6M | (944.6K) | (689.0K) | (620.1K) | (589.1K) | |
| Stock Based Compensation | 1.0M | 1.4M | 603.9K | 636.1K | 654.4K | 1.1M | |
| Cash Flows Other Operating | (1.0M) | (25.8K) | (115.4K) | (3.4M) | (3.1M) | (2.9M) | |
| Investments | 3.0M | 3.9M | (43.8M) | 14.3M | 13.0M | 13.6M | |
| Change To Operating Activities | (41.6K) | 1.1M | (4.3M) | (452.7K) | (407.5K) | (427.8K) | |
| Change Receivables | (15.4K) | 22.0K | 16.1K | (246.9K) | (222.2K) | (211.1K) | |
| Net Borrowings | (3.3M) | (1.4M) | (3.3M) | (2.3M) | (2.1M) | (2.0M) | |
| Issuance Of Capital Stock | 13.6M | 14.7M | 30.2M | (5.1K) | 404.6K | 384.3K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.